Format
Items per page
Sort by

Send to:

Choose Destination

Links from PubMed

Items: 1 to 20 of 278

1.

Bone marrow-derived mesenchymal stromal cells from patients with end-stage renal disease are suitable for autologous therapy.

Reinders ME, Roemeling-van Rhijn M, Khairoun M, Lievers E, de Vries DK, Schaapherder AF, Wong SW, Zwaginga JJ, Duijs JM, van Zonneveld AJ, Hoogduijn MJ, Fibbe WE, de Fijter JW, van Kooten C, Rabelink TJ, Roelofs H.

Cytotherapy. 2013 Jun;15(6):663-72. doi: 10.1016/j.jcyt.2013.01.010. Epub 2013 Feb 16.

PMID:
23419679
3.

Comparative study of the biological characteristics of mesenchymal stem cells from bone marrow and peripheral blood of rats.

Fu WL, Zhang JY, Fu X, Duan XN, Leung KK, Jia ZQ, Wang WP, Zhou CY, Yu JK.

Tissue Eng Part A. 2012 Sep;18(17-18):1793-803. doi: 10.1089/ten.TEA.2011.0530. Epub 2012 Jul 30.

PMID:
22721583
4.

Human embryonic stem cell-derived mesenchymal stroma cells (hES-MSCs) engraft in vivo and support hematopoiesis without suppressing immune function: implications for off-the shelf ES-MSC therapies.

Li O, Tormin A, Sundberg B, Hyllner J, Le Blanc K, Scheding S.

PLoS One. 2013;8(1):e55319. doi: 10.1371/journal.pone.0055319. Epub 2013 Jan 29.

5.

Adipose tissue-derived multipotent stromal cells have a higher immunomodulatory capacity than their bone marrow-derived counterparts.

Melief SM, Zwaginga JJ, Fibbe WE, Roelofs H.

Stem Cells Transl Med. 2013 Jun;2(6):455-63. doi: 10.5966/sctm.2012-0184. Epub 2013 May 21.

6.

Yield optimisation and molecular characterisation of uncultured CD271+ mesenchymal stem cells in the Reamer Irrigator Aspirator waste bag.

Churchman SM, Kouroupis D, Boxall SA, Roshdy T, Tan HB, McGonagle D, Giannoudis PV, Jones EA.

Eur Cell Mater. 2013 Dec 13;26:252-62.

7.

Autologous bone marrow-derived mesenchymal stromal cells for the treatment of allograft rejection after renal transplantation: results of a phase I study.

Reinders ME, de Fijter JW, Roelofs H, Bajema IM, de Vries DK, Schaapherder AF, Claas FH, van Miert PP, Roelen DL, van Kooten C, Fibbe WE, Rabelink TJ.

Stem Cells Transl Med. 2013 Feb;2(2):107-11. doi: 10.5966/sctm.2012-0114. Epub 2013 Jan 24.

8.

Lung-derived mesenchymal stromal cell post-transplantation survival, persistence, paracrine expression, and repair of elastase-injured lung.

Hoffman AM, Paxson JA, Mazan MR, Davis AM, Tyagi S, Murthy S, Ingenito EP.

Stem Cells Dev. 2011 Oct;20(10):1779-92. doi: 10.1089/scd.2011.0105. Epub 2011 Jul 6.

9.

Isolation of mesenchymal stem cells from shoulder rotator cuff: a potential source for muscle and tendon repair.

Tsai CC, Huang TF, Ma HL, Chiang ER, Hung SC.

Cell Transplant. 2013;22(3):413-22. doi: 10.3727/096368912X656090. Epub 2012 Sep 21.

PMID:
23006509
10.

Phenotypical and functional characteristics of in vitro expanded bone marrow mesenchymal stem cells from patients with systemic sclerosis.

Larghero J, Farge D, Braccini A, Lecourt S, Scherberich A, Foïs E, Verrecchia F, Daikeler T, Gluckman E, Tyndall A, Bocelli-Tyndall C.

Ann Rheum Dis. 2008 Apr;67(4):443-9. Epub 2007 May 25.

PMID:
17526552
11.

Bone marrow mesenchymal stromal cells (BM-MSCs) from healthy donors and auto-immune disease patients reduce the proliferation of autologous- and allogeneic-stimulated lymphocytes in vitro.

Bocelli-Tyndall C, Bracci L, Spagnoli G, Braccini A, Bouchenaki M, Ceredig R, Pistoia V, Martin I, Tyndall A.

Rheumatology (Oxford). 2007 Mar;46(3):403-8. Epub 2006 Aug 18.

12.

Phenotype, donor age and gender affect function of human bone marrow-derived mesenchymal stromal cells.

Siegel G, Kluba T, Hermanutz-Klein U, Bieback K, Northoff H, Schäfer R.

BMC Med. 2013 Jun 11;11:146. doi: 10.1186/1741-7015-11-146.

13.

Isolation and characterization of novel murine epiphysis derived mesenchymal stem cells.

Cheng CC, Lian WS, Hsiao FS, Liu IH, Lin SP, Lee YH, Chang CC, Xiao GY, Huang HY, Cheng CF, Cheng WT, Wu SC.

PLoS One. 2012;7(4):e36085. doi: 10.1371/journal.pone.0036085. Epub 2012 Apr 27.

14.

Profoundly reduced neovascularization capacity of bone marrow mononuclear cells derived from patients with chronic ischemic heart disease.

Heeschen C, Lehmann R, Honold J, Assmus B, Aicher A, Walter DH, Martin H, Zeiher AM, Dimmeler S.

Circulation. 2004 Apr 6;109(13):1615-22. Epub 2004 Mar 22.

15.

Investigating the efficacy of amnion-derived compared with bone marrow-derived mesenchymal stromal cells in equine tendon and ligament injuries.

Lange-Consiglio A, Tassan S, Corradetti B, Meucci A, Perego R, Bizzaro D, Cremonesi F.

Cytotherapy. 2013 Aug;15(8):1011-20. doi: 10.1016/j.jcyt.2013.03.002. Epub 2013 Apr 17.

PMID:
23602577
16.

Isolation of mesenchymal stromal cells (MSCs) from human adenoid tissue.

Lee YS, Lee JE, Park HY, Lim YS, Lee JC, Wang SG, Lee BJ.

Cell Physiol Biochem. 2013;31(4-5):513-24. doi: 10.1159/000350072. Epub 2013 Apr 2.

PMID:
23572135
17.

Human mesenchymal stem cells derived from adipose tissue reduce functional and tissue damage in a rat model of chronic renal failure.

Villanueva S, Carreño JE, Salazar L, Vergara C, Strodthoff R, Fajre F, Céspedes C, Sáez PJ, Irarrázabal C, Bartolucci J, Figueroa F, Vio CP.

Clin Sci (Lond). 2013 Aug;125(4):199-210. doi: 10.1042/CS20120644.

PMID:
23480877
19.

Mesenchymal stromal cells isolated from children with systemic juvenile idiopathic arthritis suppress innate and adaptive immune responses.

Calkoen FG, Brinkman DM, Vervat C, van Ostaijen-Ten Dam MM, Ten Cate R, van Tol MJ, Ball LM.

Cytotherapy. 2013 Mar;15(3):280-91. doi: 10.1016/j.jcyt.2012.10.017. Epub 2013 Jan 9.

PMID:
23312448
20.

Autologous bone marrow-derived mesenchymal stromal cell treatment for refractory luminal Crohn's disease: results of a phase I study.

Duijvestein M, Vos AC, Roelofs H, Wildenberg ME, Wendrich BB, Verspaget HW, Kooy-Winkelaar EM, Koning F, Zwaginga JJ, Fidder HH, Verhaar AP, Fibbe WE, van den Brink GR, Hommes DW.

Gut. 2010 Dec;59(12):1662-9. doi: 10.1136/gut.2010.215152. Epub 2010 Oct 4.

PMID:
20921206
Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk